RxDoctor Payments Data

Brandon Huffman, MD

Hematology & Oncology · Boston, MANPI 1629457056

Payments from drug & device makers

$285,435in general payments, 2019–2025

Across 4 payments — averaging $71,359 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eli Lilly$285K

What the payments were for

  • Consulting fees$1,25080%
  • Travel & lodging$32120%

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Eli Lilly4$285,435

How this compares

$285,435 in reported general payments places this provider in the 70th percentile of 374 hematology & oncology providers in Massachusetts.

See all hematology & oncology providers in Massachusetts

Medicare billing

Part B allowed, 2024
$36,625
Medicare patients
92
Services billed
276

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Prochlorperazine Maleate18$187
Olanzapine26$169
Omeprazole12$128
Ondansetron Hcl16$49

Paid to pharmacies, not to this prescriber.

Other hematology & oncology in Boston

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →